GLP-3 RT is a synthetic peptide compound currently under investigation in laboratory settings for its interactions with multiple metabolic receptors. As a triple-agonist research compound, GLP-3 RT targets three distinct receptor pathways simultaneously — glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors — making it a subject of significant interest in advanced metabolic pathway research.
This article provides an overview of GLP-3 RT’s molecular characteristics, receptor interaction mechanisms, and laboratory research applications for scientific reference purposes.
GLP-3 RT is classified as a synthetic peptide with a fatty acid chain modification that enhances its stability and receptor binding affinity in research models. Key molecular characteristics include:
Type — Synthetic peptide CAS Number — 2381089-83-2 Molecular Weight — approximately 4,731 g/mol Amino Acid Count — 39 Fatty Acid Chain — C20 diacid modification
The C20 diacid fatty acid chain is a structural feature that extends the compound’s half-life in in-vitro research models, allowing for more sustained receptor interaction studies compared to shorter chain peptide analogs.
What distinguishes GLP-3 RT from single or dual agonist peptides in research contexts is its simultaneous interaction with three receptor systems:
GLP-1 Receptor Pathway The glucagon-like peptide-1 receptor is a G protein-coupled receptor widely studied for its role in insulin secretion signaling, gastric motility modulation, and appetite regulation pathways in cellular research models. GLP-1 receptor agonism has been extensively investigated in laboratory settings for its effects on pancreatic beta cell function and glucose homeostasis signaling cascades.
GIP Receptor Pathway Glucose-dependent insulinotropic polypeptide receptor activation is studied in conjunction with GLP-1 receptor pathways for its additive effects on insulin secretion signaling in in-vitro pancreatic cell models. Research suggests that dual GLP-1 and GIP receptor co-activation may produce synergistic effects on cellular glucose uptake signaling that exceed single receptor activation in laboratory models.
Glucagon Receptor Pathway The glucagon receptor pathway is studied in metabolic research for its role in hepatic glucose production, fatty acid oxidation signaling, and energy expenditure regulation at the cellular level. Triple agonism incorporating glucagon receptor activation is of particular interest to researchers studying the interplay between anabolic and catabolic metabolic signaling pathways.
GLP-3 RT is utilized in laboratory settings for the following research applications:
Metabolic pathway signaling studies — investigating the downstream effects of simultaneous multi-receptor activation on cellular energy metabolism.
Receptor interaction analysis — studying competitive and synergistic binding dynamics between GLP-1, GIP, and glucagon receptor pathways.
In-vitro cellular response modeling — examining how triple receptor co-activation influences cellular glucose uptake, lipid metabolism, and energy homeostasis signaling.
Comparative peptide pharmacology — benchmarking triple agonist compounds against single and dual agonist analogs in controlled laboratory environments.
Peptide stability research — studying how fatty acid chain modifications affect receptor binding duration and compound stability in biological research media.
Proper storage is essential for maintaining GLP-3 RT integrity in research settings:
Lyophilized powder — stable at -20°C for 24 or more months when stored properly away from light and moisture.
Reconstituted solution — maintain at 2-8°C and use within approximately 30 days of reconstitution.
Avoid freeze/thaw cycles — repeated temperature fluctuations degrade peptide integrity and compromise research consistency.
Protect from light — UV exposure can cause molecular degradation affecting binding affinity in research models.
Keep refrigerated — even lyophilized samples benefit from consistent cold storage conditions.
Fresno Biolabs sources GLP-3 RT exclusively from US certified laboratories utilizing advanced solid-phase synthesis methods. Every batch is validated via HPLC and mass spectrometry analysis with certificates of analysis confirming purity levels of greater than 99 percent. Our compounds are independently verified for endotoxins and consistency before distribution to research institutions and qualified researchers.
GLP-3 RT represents a sophisticated research tool for scientists investigating multi-receptor metabolic signaling pathways. Its triple agonist mechanism offers a unique model for studying the complex interplay between GLP-1, GIP, and glucagon receptor systems in controlled laboratory environments. As research in this area continues to evolve, compounds like GLP-3 RT provide valuable insights into the molecular mechanisms underlying cellular metabolic regulation.
Fresno Biolabs is committed to supplying California researchers and scientific institutions with the highest quality research compounds available from verified US laboratory sources.
Disclaimer: All compounds discussed in this article are intended strictly for laboratory and in-vitro research purposes only. GLP-3 RT is not intended for human or animal consumption, therapeutic use, diagnostic application, or any purpose outside of controlled scientific research settings. This article is for informational and scientific reference purposes only. Fresno Biolabs complies with all applicable federal and state regulations regarding the distribution of research compounds.
